Transgenic mice overexpressing the pim-1 oncogene in their lymphoid compartment display a low incidence of spontaneous T-cell lymphomas, but are highly susceptible to point mutation-inducing genotoxic carcinogens. We show here that total body X-irradiation, which causes mainly chromosomal deletions, rearrangements and amplifications, significantly enhances lymphoma development in Eµ-pim-1 transgenic mice. The X-ray-induced Eµ-pim-1 and nontransgenic lymphomas have a comparable high cell turnover as shown by a relatively high S-phase fraction and a high apoptotic activity. Consistent with previous observations, in 75% of all lymphomas c-myc mRNA levels are 5-to 20-fold higher than in control, non-lymphomatous spleen/ thymus. The expression of other oncogenes, which have previously found to be activated in combination with pim-1 in lymphomagenesis, such as gfi-1/pal-1, frat-1 and tiam-1, and also of the mdm-2 and mdm-x oncogenes, appeared not to be affected. Deletions and/or rearrangements of the p16 INK4A and p15 INK4B tumor suppressor genes were seldom observed (in three out of 92 X-ray-induced lymphomas). Strikingly, in addition to the high mRNA levels of the pim-1 transgene, the levels of the endogenous pim-1 transcripts were elevated significantly in 16% of the X-ray-induced Eµ-pim-1 lymphomas compared with control spleen, even surpassing the level of the pim-1 transgene mRNA by 3-to 5-fold. In combination with previous results, which showed that the lymphoma incidence increased concordantly with higher levels of pim-1, this supports the notion that pim-1 can contribute to lymphomagenesis in a dosedependent manner.
Introduction
The pim-1 gene was discovered as a preferential proviral integration site in murine leukemia virus (MuLV*)-induced Tcell lymphomas (1, 2) . The evidence that pim-1 contributes to human carcinogenesis is limited to a few cases where elevated mRNA and protein levels were found in tumor material and cell lines (3) (4) (5) . In mice, however, extensive transgenic studies have confirmed that pim-1 indeed can act as an oncogene (6, 7) . The normal functions of pim-1, which encodes two related protein serine/threonine kinases (8) , have remained largely obscure. Pim-1 is expressed predominantly in testis and hematopoietic tissues, especially early in development (3, 6) , where it probably functions in signal transduction.
Overexpression of pim-1 in the hematopoietic system using the immunoglobulin enhancer (Eµ), predisposes mice to a low incidence (5-10%) of spontaneous T-cell lymphomas before the age of 7 months (6). However, exposure to chemical carcinogens, such as the alkylating agent N-ethyl-N-nitrosourea (ENU) (9, 10) , the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo- [4,5-b] pyridine (PhIP) (11) or benzo[a]pyrene (BaP) (12) , significantly accelerated tumor development. These genotoxic agents, that act directly (ENU) or after being metabolized (PhIP, BaP), form different types of DNA adducts, which, if left unrepaired cause mainly point mutations.
In contrast, ionizing radiation induces large chromosomal deletions and other major chromosomal changes such as rearrangements and amplifications (13) , and it is highly effective in producing lymphomas in mice (14) . In the present study, we have evaluated the frequency and characteristics of lymphomas in Eµ-pim-1 mice after exposure to fractionated total body X-irradiation. Possible target genes involved in Xray-induced lymphomas are the members of the myc family, which are frequently activated by chromosomal amplifications or rearrangements in some types of human (15) and murine tumors (16) . Previous studies have shown that c-myc and Nmyc synergize effectively with pim-1 in lymphomagenesis (6, 9, 17) . Other genes found to be activated in combination with pim-1 in lymphomagenesis include gfi-1/pal-1 (18, 19) , frat-1 (20) and tiam-1 (21) . However, as these latter genes were originally identified in MuLV-induced lymphomagenesis, it is of interest to investigate if they are also involved in Xray-induced lymphomas.
Possible other candidates to be inactivated in our X-rayinduced lymphomas are the p16 INK4A and p15 INK4B tumor suppressor genes, which appear to be deleted in many different human lymphomas and leukemias (22, 23) . Reported loss of heterozygosity-events around the p16 INK4A and p15 INK4B loci in X-ray-induced mouse thymic lymphomas (24) support a role for these genes in murine lymphomagenesis as well.
Materials and methods

Transgenic mice and tumor induction
Heterozygous Eµ-pim-1 transgenic mice (6) used in this study had been produced after back-crossing to C57BL/6JIco mice for at least 12 generations. At 4-7 weeks of age, Eµ-pim-1 mice and non-transgenic litter-mates were exposed to total body X-irradiation (Smart 225, Andrex; dose rate: 0.1 Gy/ min) in a split-dose regimen with a 7-day interval. The following doses were used: 4ϫ1.5 Gy (12 female and 14 male Eµ-pim-1 mice; 15 female and 18 male non-transgenic mice), 4ϫ1.0 Gy (15 female and 11 male Eµ-pim-1 mice; 15 female and 16 male non-transgenic mice), 4ϫ0.5 Gy (32 female and 31 male Eµ-pim-1 mice; 25 female and 38 male non-transgenic mice), or no treatment (13 female and 12 male Eµ-pim-1 mice; 13 female and 11 male non-transgenic mice). Mice were housed conventionally, with water and standard lab chow ad libitum. They were examined twice a week for signs of illness and killed when moribund or 250 days after the last exposure to X-irradiation. During the observation period of 250 days, two non-transgenics exposed to 4ϫ1.5 Gy, 4 Eµ-pim-1 transgenics exposed to 4ϫ1.0 Gy, and 2 Eµ-pim-1 and one non-transgenic exposed to 4ϫ0.5 Gy died from unknown causes and were excluded from the experimental groups.
Tissue samples and immunohistochemistry
At autopsy, all animals were analyzed for macroscopic signs of lymphoma development, such as enlarged or atypical spleen, thymus and/or lymph nodes. Spleen, thymus, lymph node, liver, lung, kidney, and occasionally, intestine, muscle, heart and testis were isolated and fixed in 10% phosphate-buffered formalin for histological sections, or snap-frozen and stored at -80°C for RNA/DNA analysis. In addition, lymphomatous and control, non-lymphomatous spleens were frozen in isopentane for immunohistochemical phenotyping.
Paraffin-embedded sections were prepared by routine methods and stained with hematoxylin and eosin. Lymphomatous tissues of 35 X-irradiated Eµ-pim-1 mice and of all X-irradiated non-transgenic (n ϭ 25) mice were examined histologically. In addition, spleens and thymuses with macroscopic signs of lymphoma development at the final autopsy were similarly examined. Isopentane-frozen sections (5 µm) of lymphomatous spleen of three Eµ-pim-1 and three non-transgenic mice exposed to 4ϫ1.5 Gy, and control nonlymphomatous spleen of three Eµ-pim-1 and three non-transgenic untreated mice, were incubated with monoclonal antibodies against cell surface marker CD3 (rat anti-mouse γCD3; Department of Pathology, Leiden), B220 (rat antimouse CD45/B220; Pharmingen), CD8 (rat anti-mouse GK1.5; Department of Pathology, Leiden) or CD4 (rat anti-mouse H35-17.2; Department of Pathology, Leiden), and with appropriate FITC-conjugated second antibodies (Pharmingen) according to standard procedures. Lymphomas negative for B220, positive for CD3 and CD4 or CD8 were classified as T-cell lymphomas, whereas lymphomas positive for B220 and negative for CD3 were classified as B-cell lymphomas.
In situ detection of mitotic and apoptotic cells
At 1 h prior to autopsy, moribund mice were injected i.p. with 50 mg bromodeoxyuridine (BrdU) per kg body weight, freshly dissolved in phosphatebuffered saline. Spleen tissue was collected and treated as described (25). BrdU-incorporating cells were visualized with the help of the anti-BrdU monoclonal antibody IU-4 (Caltag) and an appropriate peroxidase-conjugated second antibody (Caltag). To facilitate the identification of cells undergoing apoptosis, DNA breaks were labeled in situ on tissue sections with the TUNEL method, essentially as described (26) . To obtain satisfactory staining, samples were heated to 80°C prior to labeling, and as a consequence part of the normal morphology was lost. Quantification of cells in S phase or in apoptosis was achieved by counting all cells (~100) in three, high-power light microscopic fields (ϫ40). S-phase and apoptotic indices were determined as the percentage of positive-stained cells relative to total counted cells. Mean indices were compared with the Student's t-test.
DNA and RNA analysis
For Southern blot analysis, 10 µg total high molecular-weight genomic DNA was digested with restriction enzymes as recommended by the supplier, separated on agarose gels and transferred to N ϩ -Hybond membranes (Amersham). For Northern blot analysis, 25 µg total RNA isolated by the guanidinium-isothiocyanate method (27) was separated on agarose gels containing formaldehyde and transferred to N-Hybond membranes (Amersham). Filters were hybridized with 32 P-labeled probes and washed according to standard procedures. The signal was quantified with a PhosphorImager (Molecular Dynamics).
For Northern and Southern blots the following probes were used: 86T5: recognizes the constant region of murine T-cell receptor (TCR) β2 and β1 genes (28) 
Results
Lymphoma incidence in Eµ-pim-1 transgenic mice exposed to total body X-irradiation
Groups of 4-to 7-week-old Eµ-pim-1 transgenic and nontransgenic control mice were exposed to four weekly doses of 1.5 Gy, 1.0 Gy or 0.5 Gy total body X-irradiation and monitored for lymphoma development during 250 days after the last exposure. A control group of untreated Eµ-pim-1 and nontransgenic mice was observed concurrently. All 26 Eµ-pim-1 mice exposed to 4ϫ1.5 Gy X-ray developed lymphomas within 250 days, whereas 12 of the 31 similarly irradiated nontransgenic animals survived through this period without showing any behavioral or, at the final autopsy, macroscopic pathological signs of lymphoma development. Of the recipients of the lower doses of 4ϫ1.0 Gy or 4ϫ0.5 Gy X-ray, 20 out of 22, and 17 out of 61, respectively, Eµ-pim-1 mice developed a lymphoma within the observation period. In contrast, only six out of 31 and none out of 62, respectively, non-transgenic mice exposed to the same doses of X-ray acquired a lymphoma ( Figure 1a) . From the data presented in Figure 1a it can be calculated via the method described by Breuer et al. (10) that the Eµ-pim-1 mice were at least 3-fold more sensitive to fractionated total body X-irradiation than the non-transgenic mice. Remarkably, at all doses female X-ray-treated Eµ-pim-1 as well as non-transgenic mice developed lymphomas somewhat earlier than the corresponding male mice. At the end of the observation period, however, in each treatment group a similar lymphoma incidence was found in females as well as males (Figure 1b) .
The incidence and latency periods for X-ray-induced lymphomas in the non-transgenic mice in this study correspond well to literature data on lymphomagenesis in C57BL/6J mice (14) . None of the untreated non-transgenic mice showed any signs of lymphoma development during the observation period, whereas in three (12%) untreated Eµ-pim-1 mice a lymphoma was detected, which is in good accordance with the reported rate of spontaneous lymphoma development in these mice (6, 9, 10) .
Histopathology of X-ray-induced lymphomas
Moribund X-ray-treated Eµ-pim-1 as well as non-transgenic mice presented at autopsy with massive splenomegaly and/or an enlarged thymus and, in most cases, enlarged peripheral and mesenteric lymph nodes. At the final autopsy, 250 days after the last exposure to X-ray, similar macroscopic characteristics were noted in six Eµ-pim-1 mice [4ϫ0.5 Gy (n ϭ 1), 4ϫ1.0 Gy (n ϭ 4), 4ϫ1.5 Gy (n ϭ 1)]. Histopathological analysis of the macroscopically identified lymphomas revealed features that were consistent with a lymphoblastic lymphoma/ leukemia as classified by Pattengale and Taylor (35) , which is similar in this respect to spontaneous lymphomas that occurred in Eµ-pim-1 mice [this study; (6)]. In all lymphoma-bearing mice of this study, lymphoblastoid cells were always found in kidneys, liver and lung, and occasionally in other tissues including testis, heart, skeletal muscle and intestine.
Eighty two (92%) lymphomas were classified as T-cell lymphomas, based on the detection of clonal rearrangements of the T-cell receptor (TCR)-β genes (data not shown). The T-cell origin of the lymphomas was confirmed by immunohistochemical analysis of six representative lymphomas (three Eµ-pim-1 and three non-transgenic), which were B220 -/CD3 ϩ / CD4 -/CD8 ϩ . Immunophenotyping of the seven tumors that did not display rearranged TCRβ genes revealed three B-cell lymphomas (B220 ϩ /CD3 -: two Eµ-pim-1 and one nontransgenic) and four T-cell lymphomas (B220 -/CD3 ϩ /CD4 ϩ / CD8 -: three Eµ-pim-1 and one non-transgenic). In one Eµ-pim-1 B-cell lymphoma, the B-cell origin was confirmed by the presence of a clonal rearrangement of the Igκ light chain (data not shown).
Mitotic and apoptotic indices of X-ray-induced lymphomas
Previous data have indicated that pim-1 might function as an inhibitor of apoptosis (36) , and possibly contributes thus to the increased penetrance and reduced latency of lymphoma development in Eµ-pim-1 transgenic mice. On the other hand, high Pim-1 protein levels also enhance the response of hematopoietic cells to growth factors (37) . In order to investigate if the pim-1 transgene affects these processes in the Xray-induced lymphomas, both mitotic and apoptotic indices were determined. However, X-ray-induced and spontaneous Eµ-pim-1-derived lymphomas did not differ significantly from non-transgenic-derived lymphomas in the percentage of cells in S phase (Table I) . Thus all lymphomas, as expected for tumor tissue, displayed a significant (14-to 28-fold) increase of proliferative activity compared with control, non-lymphomatous spleen tissue. Concomitant with the enhanced proliferative activity, Eµ-pim-1 and non-transgenic lymphomas displayed comparable, at least 5-fold higher apoptotic indices than control spleen tissues (Table I) . 
BrdU and TUNEL-staining was performed on spleen tissue. Moribund, lymphoma-bearing X-ray-treated Eµ-pim-1 [4ϫ1.5 Gy (n ϭ 6), 4ϫ1.0 Gy (n ϭ 2), 4ϫ0.5 Gy (n ϭ 1)] and non-transgenic mice [exposed to 4ϫ1.5 Gy (n ϭ 7), respectively 4ϫ1.0 Gy (n ϭ 2)] were injected with the S-phase marker BrdU. As controls, untreated lymphomatous (n ϭ 3) and nonlymphomatous (n ϭ 5) Eµ-pim-1, and non-lymphomatous non-transgenic mice (n ϭ 5) were also injected with BrdU. Percentages were determined as described in Materials and methods. For the BrdU staining 2 Eµ-pim-1 and 2 wild-type-derived sections, and for the TUNEL staining one Eµ-pim-1 and 2 wild-type-derived sections proved to be non-informative because of staining artifacts.
Activation of oncogenes in X-ray-induced lymphomas
Previous studies have revealed strong co-operation between pim-1 and members of the myc oncogene family in lymphomagenesis (6, 7, 9) . After exposure to X-ray, 75% of the lymphomas (44 out of 61 Eµ-pim-1-derived and 22 of 25 non-transgenicderived) showed a 5-to 20-fold increased c-myc expression over that seen in control, non-lymphomatous spleen (examples are shown in Figure 2a ). The remaining 25% of the lymphomas displayed no significant change in c-myc expression, which indicates that the observed high c-myc expression is probably not a mere reflection of the differentiation or growth state of the lymphomas. In general, N-myc levels were not affected in the T-cell lymphomas: only one non-transgenic-derived B-cell lymphoma overexpressed N-myc, in addition to a 7-fold elevated c-myc expression (Figure 2a, lymphoma 231) . It has been shown that some Eµ-pim-1-derived lymphomas expressed increased levels of endogenous pim-1 transcripts, on top of the already high level of the pim-1 transgene transcript (9, 10) . This suggested a dose-response relationship for the oncogenic effect of Pim-1, which was confirmed by the observation that mice homozygous for the Eµ-pim-1 transgene developed lymphomas at a higher incidence and after a shorter latency than heterozygous Eµ-pim-1 mice (37-39). In accordance with this hypothesis, 16% of X-rayinduced Eµ-pim-1 lymphomas showed high, in two cases even extremely high (ജ30-fold increase in lymphomas 141 and 150 over normal endogenous levels; Figure 2b ) endogenous pim-1 transcript levels, which even surpassed the mRNA levels derived from the pim-1 transgene by 3-to 5-fold (data not shown). Also, non-transgenic X-ray-induced lymphomas revealed a Ͼ5-fold increased expression of endogenous pim-1 transcripts in six cases (24%) (Figure 2b) .
In order to investigate other molecular events that contribute to the development of these lymphomas, expression levels of oncogenes that have been identified in Eµ-pim-1 transgenic mice in MuLV-induced lymphomagenesis, such as gfi-1/pal-1 (18, 19) , frat-1 (20) and tiam-1 (21) were measured. As shown in Figure 2c , we detected gfi-1 transcripts in the X-ray-induced lymphomas, however, the expression remained several-fold below the levels observed in the positive control, a MuLV- Fig. 2 . Northern blot analysis of X-ray-induced lymphomas of Eµ-pim-1 and non-transgenic mice. Total RNA was isolated from lymphomatous and control, non-lymphomatous spleen tissue. wt, Expression level in control, non-lymphomatous spleen of wild-type (non-transgenic) mice; tg, expression level in control spleen of Eµ-pim-1 mice; Nϩ*, positive control for increased N-myc expression levels. [This lymphoma carrier bears a proviral insertion in the 3Ј untranslated region of the N-myc gene, resulting in high expression of a slightly shorter transcript (17)]; cϩ, positive control displaying increased c-myc expression levels comparable with the levels found in lymphomas with a provirally activated c-myc; cϩ*, positive control displaying increased c-myc levels due to a provirally activated c-myc (53) . gϩ, positive control displaying 2-to 3-fold increased levels of gfi-1 mRNA over normal T cells because of a proviral insertion at the locus (kindly provided by B.Scheijen, NKI, Amsterdam, The Netherlands). For a loading control, the blots were hybridized to an actin probe. induced T-cell lymphoma that has been shown to have 2-to 3-fold increased gfi-1 mRNA levels compared with control, non-lymphomatous T cells (B.Scheijen, pers. comm.). Therefore, gfi-1 expression appeared not to be increased in these lymphomas. Similarly, the expression pattern of pal-1, a transcript derived from the same locus, was not changed (data not shown). With respect to frat-1 and tiam-1, Northern blot analysis did not reveal aberrant expression levels of these genes either (data not shown). Fig. 3 . Northern blot analysis of mdm-2 expression levels in control, nonlymphomatous spleen and thymus, derived from untreated Eµ-pim-1 and non-transgenic mice. For a loading control, the blot was hybridized to an actin probe.
An interesting candidate that may be involved in the etiology of these lymphomas is the mdm-2 oncogene, which has been reported to be overexpressed in various human lymphomas and leukemias (40) (41) (42) . The mdm-2 mRNA transcript levels in the lymphomas were 2-to 5-fold higher than control, nonlymphomatous spleen, but not when compared with control thymus, which indicates that the upregulation of mdm-2 expression is probably caused by the T-cell origin of the lymphomas, rather than that it has contributed to their development (data not shown). This was confirmed by the detection of the 2-to 3-fold increased expression levels of mdm-2 in control, non-lymphomatous thymus compared with control spleen, regardless of the presence or absence of the Eµ-pim-1 transgene (Figure 3) . p16 INK4A 
and p15 INK4B deletions in X-ray-induced lymphomas
Loss of heterozygosity-analysis of ionizing radiation-induced murine thymic lymphomas has revealed deletions of regions of chromosome 4 around the p16 INK4A and p15 INK4B loci in 40% of tumors, which potentially implicates the loss of these tumor-suppressor genes in the development of murine lymphomas (24) . In order to investigate whether these genes play a role in our X-ray-induced lymphomas, the genomic organization of p16 INK4A and p15 INK4B was investigated by quantitative Southern blot analysis. We did indeed observe p16 INK4A and/or p15 INK4B deletions, but only with a low frequency (three lymphomas out of 92). As shown in Figure 4 , the p16 INK4A and p15 INK4B genes are homozygously deleted in lymphoma 209 (Eµ-pim-1), as their signal is reduced significantly in DNA of lymphomatous spleen, and is nearly absent from the lymph nodes, because of their lower content of contaminating non-tumor cells (Figure 4) . In lymphoma 222 (Eµ-pim-1), one allele of the p15 INK4B gene is rearranged and the p16 INK4A signal is heterozygously deleted as shown by a 50% reduction of the signal. Interestingly, lymphoma 117 (non-transgenic) carries a homozygous deletion of only the p15 INK4B gene (Figure 4) .
Discussion
In this paper we report that Eµ-pim-1 transgenic mice are highly susceptible to lymphomagenesis induced by total body X-irradiation, a directly acting carcinogenic agent, which induces large chromosomal deletions and rearrangements (13) . For all doses of X-ray tested (4ϫ1.5 Gy, 4ϫ1.0 Gy and 4ϫ0.5 Gy), exposed Eµ-pim-1 mice developed lymphomas at a higher incidence and with a reduced latency than non-transgenic or untreated Eµ-pim-1 mice (Figure 1) . The highest discriminating effect was obtained with a dose of 4ϫ1.0 Gy: nearly all Eµ- 
pim-1 mice (91%) developed lymphomas, in contrast to few non-transgenic mice (19%).
The Eµ-pim-1 mouse strain has been analyzed by various laboratories in short-term in vivo carcinogenicity tests with directly acting carcinogens or procarcinogens that require metabolic activation (11, 12, 43) . Eµ-pim-1 mice were found to be very sensitive to most chemical (pro)carcinogens that have the lymphoid system as their target. These carcinogens, however, induce mainly point mutations, whereas X-irradiation, an effective lymphomagenic agent, causes predominantly large chromosomal aberrations. In combination with the present study, all these data indicate that organ specificity rather than mutation spectrum of the (pro)carcinogen determines the susceptibility of Eµ-pim-1 mice. In addition, the extent of the increase in sensitivity of Eµ-pim-1 mice compared with nontransgenic mice seems to depend on the agent tested, e.g. 25-fold for ENU (10), 5-fold for BaP (12) and 3-fold for X-rays (this study). It is possible that the observed differences are related to the age at which the animals were treated, as ENU was administered at 2 weeks of age, whereas the BaP treatment and the total body X-irradiation were started only at 4-8 weeks of age.
In contrast to the treatment with the carcinogen BaP (12), but similar to PhIP (11), exposure to X-ray resulted in a slightly faster development of lymphomas in female than male Eµ-pim-1 mice (Figure 1b) . In fact, X-ray-treated nontransgenic females (Figure 1b) and even untreated Eµ-pim-1 females (11, C.W.van der Houven van Oordt, unpublished data) developed lymphomas earlier than the corresponding male mice. This accelerated lymphoma development in females might be because of constitutional differences in their hematopoietic system. In this connection it is interesting to note that prolactin increases the viability of thymocytes (44, 45) .
In contrast to reports that have indicated that pim-1 might confer an enhanced responsiveness to growth factors (37) and a reduction of apoptosis (36) , our X-ray-induced Eµ-pim-1 and non-transgenic-derived lymphomas had similar percentages of 851 cells in S phase as well as apoptosis (Table I) . Possibly, pim-1 has been activated in some of the non-transgenic lymphomas as well, which precludes the possibility to observe clear differences in S phase and apoptosis between Eµ-pim-1 and non-transgenic-derived X-ray-induced lymphomas. Alternatively, pim-1 may have exerted its oncogenic effect via other pathways. Interestingly, recent results have implicated Pim-1 in the stimulation of c-Myc-mediated apoptosis in Rat-1 fibroblasts (46) , which suggests that Pim-1 function might depend on the cell type and its condition.
Although it is thus still unknown by which mechanism(s) pim-1 stimulates lymphoma development, increasing levels of Pim-1 promote lymphomagenesis in a dose-dependent manner. Previous results have shown that homozygous Eµ-pim-1 transgenic mice display a much higher lymphoma incidence (40% within a year) than heterozygous Eµ-pim-1 mice (5-10% within a year) (37) (38) (39) . This dose-effect is also noted for homozygous Pim-1 deficient mice, which are more resistant to MuLV-induced lymphomagenesis than mice with one nonfunctional pim-1 allele (47). These results indicate that the level of (over)stimulation of the pim-1 pathway determines the incidence of lymphoma development. Thus, the observed high levels of the endogenous pim-1 transcripts in our Xray-induced lymphomas (both Eµ-pim-1 and non-transgenic), which exceeds those of the pim-1 transgene by several-fold (Figure 2b) , are likely to have significantly contributed to lymphomagenesis.
In Eµ-pim-1-derived lymphomas, an increase in c-myc expression has been found on a very regular basis (6, 9) , and in this study, we found that 75% of the X-ray-induced lymphomas expressed high levels of c-myc mRNA. However, in 25% of the lymphomas, the expression level of c-myc was comparable to that found in non-lymphomatous spleen/thymus. This indicated that, although frequently occurring, high levels of c-myc transcripts are not a prerequisite for lymphoma development, nor the result of growth and/or differentiation characteristics of these otherwise highly similar T-cell lymphomas. Similar observations have been made regarding other lymphomas in Eµ-pim-1 mice (9). In addition, previous results have shown that co-expression of both c-myc and pim-1 in transgenic mice caused a very strong co-operative effect (development of pre-B-cell leukemias in utero) (7) , which stresses the functional significance of the observed increase in c-myc transcripts in X-ray-induced lymphomagenesis. We did not detect any gross chromosomal aberrations in the c-myc gene that could explain the observed activation of c-myc (data not shown), however, the presence of small deletions, rearrangements or point mutations cannot be excluded.
Investigation of other genes such as gfi-1/pal-1 (18, 19) , frat-1 (20) and tiam-1 (21) did not reveal changed expression in the X-ray-induced lymphomas. Replication of radiation leukemia virus (RadLV) was not observed in any of our lymphomas, which has been implicated in the etiology of radiation-induced lymphomas (48) , nor of endogenous retroviruses, which were shown to be activated in chemicallyinduced lymphomas (49) (data not shown).
Another potential target that might be involved in lymphomagenesis induced by total-body X-irradiation is the p53 pathway. P53 itself appears not be affected, as we have previously shown that Eµ-pim-1 lymphomas do not harbor aberrant p53 (12) . In addition, X-ray-induced lymphomas in C57BL/6 mice show only a low percentage of p53 mutations (50) . Yet the p53-regulating mdm-2 oncogene, which is frequently activated in human lymphoid tumors (40) (41) (42) , appears to be overexpressed in nearly all of the X-ray-induced lymphomas. This increase, however, was shown to be T-cell-related rather than tumor-specific (Figure 3) , suggesting that the mdm-2 p53-pathway is not disturbed in these X-ray-induced lymphomas. Saez et al. report that the mdm-2 p53-pathway is also not affected in γ-ray-induced lymphomagenesis (51) . Recently, we have identified a novel mdm-2 family member, mdm-x (32), which, judging from Northern blot analysis, was not activated either (data not shown).
A further growth inhibitory route that could be involved is the p16 INK4A /cyclin D/Rb pathway. In human lymphomas and leukemias, the cyclin-D inhibitors p16 INK4A and p15 INK4B are frequently deleted, especially in those of T-cell origin (22, 23) . In our murine X-ray-induced lymphomas, however, loss of the p16 INK4A and p15 INK4B genes occurred in only 3% of the cases (Figure 4) . Recently, similar low frequencies of p16 INK4A and p15 INK4B deletions have been reported for murine T-cell lymphomas induced by various agents (52) . Thus, the loss of heterozygosity-events found on chromosome 4 around the p16 INK4A and p15 INK4B loci in γ-ray-induced murine thymic lymphomas (24) probably indicate the involvement of other genes located in the close vicinity of the locus.
The X-ray-induced lymphomas do not show frequent inactivating genomic deletions nor rearrangements of potential target genes, such as the p16 INK4A and p15 INK4B genes (Figure 4) , nor gross chromosomal aberrations that lead to the observed activation of c-myc and pim-1 (data not shown). Although chromosomal abnormalities, such as trisomy 15, which is frequently found in X-ray-induced murine T-cell lymphomas (16) , cannot be excluded on the basis of our analysis, the failure to detect frequent gross genomic aberrations could also point to other mutational mechanisms such as small deletions, (in)activating point-mutations, or a changed expression of specific trans-activating and/or inhibiting factors.
In conclusion, this study has extended the evaluation of the Eµ-pim-1 strain in short-term carcinogenicity assays (9) (10) (11) (12) 43) . The data from all the studies combined suggest that Eµ-pim-1 mice are best suited for testing agents that have the lymphoid system as target. In most cases, including ours, however, only limited information is available about the molecular events that, in combination with pim-1, have led to lymphoma development. One way to further investigate such co-operating genes is the differential display technique by which changes of gene expression are identified without prior knowledge of the genes involved.
